What is Biossance?
Biossance is a company operating within the biotechnology and sustainable materials sector, focusing on the development and production of innovative solutions. While specific details about its core products are not provided, its funding context suggests a focus on scaling production and expanding market reach. The company's recent capital injections indicate a strong investor confidence in its business model and future prospects, positioning it for significant advancements in its field.
How much funding has Biossance raised?
Biossance has raised a total of $62K across 1 funding round:
Debt
$62K
Debt (2021): $62K with participation from PPP
What's next for Biossance?
With substantial expansion capital secured, Biossance is poised for a period of accelerated growth. This funding is expected to fuel strategic initiatives, potentially including increased manufacturing capacity, research and development into new product lines, and broader market penetration. The company's progression through Series B/C funding stages signals a move towards solidifying its market position and achieving greater operational scale, preparing it for future milestones and potential profitability.
See full Biossance company page
